Protocol Ingestion & Criteria Decomposition
Upload an oncology protocol or select a clinical template to extract machine-executable inclusion and exclusion rules.
1Select Protocol Source
Choose a verified oncology trial template or paste custom protocol text
Phase IIINCT04035486
Phase III Osimertinib + Chemotherapy in Advanced EGFR-Mutated NSCLC
A randomized, open-label, international multi-center Phase 3 study evaluating frontline third-generation EGFR-TKI in patients with EGFR exon 19 deletion or L858R mutation.
Phase IINCT03734029
Phase II Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer
A Phase 2 multicenter study of antibody-drug conjugate (T-DXd) in patients with pretreated HER2-low unresectable or metastatic breast adenocarcinoma.
Automatic Safe-Harbor 18-Identifier De-identification Active